eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

GlaxoSmithKline UK

Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 10/06/2010
PIL Augmentin 375mg Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 10/06/2010 and displayed until Current
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change to date of revision
Updated on 20/10/2008 and displayed until 10/06/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to date of revision
  • Change due to user-testing of patient information
Updated on 24/01/2005 and displayed until 20/10/2008
Reasons for adding or updating:
  • Change to side-effects
Updated on 30/07/2004 and displayed until 24/01/2005
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 14/05/2003 and displayed until 30/07/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 10/05/2002 and displayed until 14/05/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 20/09/2000 and displayed until 10/05/2002
Reasons for adding or updating:
  • No reasons supplied
Updated on 10/08/2000 and displayed until 20/09/2000
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   co-amoxiclav